000 03636cam a2200625 i 4500
001 on1374215010
003 OCoLC
005 20241121073136.0
006 m d
007 cr cnu---unuuu
008 230329t20232023enk ob 001 0 eng d
040 _aN$T
_beng
_erda
_epn
_cN$T
_dN$T
_dUKMGB
_dOCLCF
_dOCLCO
015 _aGBC2I2046
_2bnb
016 7 _a020774092
_2Uk
019 _a1376273950
020 _a9781839165887
_q(electronic bk.)
020 _a183916588X
_q(electronic bk.)
020 _z1788018982
020 _z9781788018982
035 _a3580101
_b(N$T)
035 _a(OCoLC)1374215010
_z(OCoLC)1376273950
037 _a3-178-9781839165887
_bIngram Content Group
050 4 _aRS403
_b.H34 2023
082 0 4 _a615.19
_223
049 _aMAIN
245 0 4 _aThe handbook of medicinal chemistry :
_bprinciples and practice /
_cedited by Simon E. Ward and Andrew M. Davis.
250 _a2nd edition.
264 1 _aCambridge :
_bRoyal Society of Chemistry,
_c[2023]
264 4 _c�2023
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
588 0 _aPrint version record.
500 _aPrevious edition: 2015.
504 _aIncludes bibliographical references and index.
505 0 _aPhysicochemical Properties; Synthesis in Medicinal Chemistry; Useful Computational Chemistry Tools for Medicinal Chemistry; Structure-based Design for Medicinal Chemists; Fragment-based Ligand Discovery; Machine Learning in Drug Design; Drug Metabolism; ADME Optimization in Drug Discovery; Molecular Biology for Medicinal Chemists; Assays; In Vitro Biology: Measuring Pharmacological Activity That Will Translate to Clinical Efficacy; Animal Models: Practical Use and Considerations; Bioinformatics for Medicinal Chemistry; Translational Science; Discovery Toxicology in Lead Optimization; Toxicology and Drug Development; Patents for Medicines; Target Validation for Medicinal Chemists; Lead Optimisation: What you should know!; Pharmaceutical Properties -- The Importance of Solid Form Selection; The Medicinal Chemistry and Process Chemistry Interface; Clinical Drug Development; SMN2 Splicing Modification by Small Molecules -- A Blueprint to Tackle the Underlying Genetic Cause of Many Underserved Diseases; The Discovery of Checkpoint Kinase 1 Inhibitors: From Fragments to Clinical Candidate; Medicinal Chemistry for Neglected Diseases -- Malaria, Tuberculosis, Sleeping Sickness, Leishmaniasis and River Blindness; New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery
590 _aWorldCat record variable field(s) change: 650
650 0 _aPharmaceutical chemistry.
_917664
650 0 _aDrug development.
_915871
650 0 _aDrugs.
_923599
650 2 _aChemistry, Pharmaceutical
_923600
650 2 _aPharmaceutical Preparations
_923601
650 6 _aChimie pharmaceutique.
_923602
650 6 _aM�edicaments
_xD�eveloppement.
_915872
650 6 _aM�edicaments.
_923603
650 7 _aDrug development
_2fast
_915871
650 7 _aPharmaceutical chemistry
_2fast
_917664
700 1 _aWard, Simon E.
_q(Simon Edward),
_eeditor.
_923604
700 1 _aDavis, Andrew M.
_c(Chemist),
_eeditor.
_923605
776 0 8 _iPrint version:
_tHANDBOOK OF MEDICINAL CHEMISTRY.
_d[Place of publication not identified] : ROYAL SOCIETY OF CHEMISTR, 2022
_z1788018982
_w(OCoLC)1331704492
856 4 0 _3EBSCOhost
_uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3580101
938 _aEBSCOhost
_bEBSC
_n3580101
994 _a92
_bN$T
999 _c8840
_d8840